Fludder J M, Leonard B E
Psychopharmacology (Berl). 1979 Sep;64(3):329-32. doi: 10.1007/BF00427519.
Chronic administration of the pre-synaptic alpha-adrenoreceptor agonist clonidine decreases the concentration of the extra-neuronal metabolite of noradrenaline normetanephrine in the amygdaloid cortex and increases it in the mid-brain. Conversely, blockade of these pre-synaptic receptors by yohimbine increases the normetanephrine concentration in the amygdaloid cortex and decreases it in the mid-brain. Mianserin had a qualitatively similar action to that of yohimbine. When given clinically to rats in combination with clonidine, mianserin antagonizes both the depression of behaviour of the rats in the 'open field' apparatus and also the effects of the alpha-agonist in reducing the concentration of normetanephrine in the amygdaloid cortex. It thus appears that the chronic effects of mianserin are due to an increase in noradrenaline release as a consequence of the inhibitation of pre-synaptic alpha-adrenoreceptors.
长期给予突触前α-肾上腺素能受体激动剂可乐定,可降低杏仁核皮质中去甲肾上腺素的细胞外代谢产物去甲变肾上腺素的浓度,并使其在中脑中的浓度升高。相反,育亨宾对这些突触前受体的阻断作用会增加杏仁核皮质中去甲变肾上腺素的浓度,并降低其在中脑中的浓度。米安色林的作用在性质上与育亨宾相似。当在临床上将米安色林与可乐定联合给予大鼠时,米安色林既能拮抗大鼠在“旷场”装置中的行为抑制,也能拮抗α-激动剂降低杏仁核皮质中去甲变肾上腺素浓度的作用。因此,米安色林的长期作用似乎是由于突触前α-肾上腺素能受体受到抑制,导致去甲肾上腺素释放增加所致。